← Back to Search

MRI

Portable MRI for Hydrocephalus

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or older

Suspected or confirmed diagnosis of hydrocephalus from Penn referring physician

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 60 minutes

Awards & highlights

Study Summary

This trial is testing whether a portable, low field strength MRI system is feasible and acceptable to use in an outpatient setting, and whether it provides diagnostic information comparable to that of standard clinical MRI or CT scans.

Who is the study for?

This trial is for adults over 18 with suspected or confirmed hydrocephalus or other neurological disorders, as determined by a Penn physician. Participants must be scheduled for standard brain imaging on the same day as the Hyperfine MRI scan and able to give informed consent. It's not suitable for individuals with certain metal implants, uncontrolled seizures, severe claustrophobia, weight over 400lbs, pregnant women, or those unable to follow study procedures.Check my eligibility

What is being tested?

The trial tests a portable MRI system called Hyperfine in outpatients needing brain scans due to hydrocephalus or other neurological issues. The goal is to see if this low field strength MRI can be used conveniently in an outpatient setting and how well it compares with standard CT/MRI scans done on the same day.See study design

What are the potential side effects?

Since the intervention involves only non-invasive imaging using a portable MRI machine (Hyperfine), there are no direct side effects like you would expect from medication. However, patients may experience discomfort similar to that of regular MRIs such as loud noises during scanning or feelings of claustrophobia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My doctor suspects or has confirmed I have hydrocephalus.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 60 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 60 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hydrocephalus

Presence of other important imaging findings

Quantitative ventricular volumes

Trial Design

2Treatment groups

Experimental Treatment

Group I: Outpatients with other known or suspected neurological conditionExperimental Treatment1 Intervention

Group II: Outpatients with known or suspected hydrocephalusExperimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,002 Previous Clinical Trials

42,880,899 Total Patients Enrolled

1 Trials studying Hydrocephalus

2 Patients Enrolled for Hydrocephalus

Media Library

Hyperfine MRI scan (MRI) Clinical Trial Eligibility Overview. Trial Name: NCT04436068 — N/A

Hydrocephalus Research Study Groups: Outpatients with known or suspected hydrocephalus, Outpatients with other known or suspected neurological condition

Hydrocephalus Clinical Trial 2023: Hyperfine MRI scan Highlights & Side Effects. Trial Name: NCT04436068 — N/A

Hyperfine MRI scan (MRI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04436068 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many study participants are currently being monitored in this investigation?

"Affirmative. Clinicaltrials.gov suggests that this clinical trial is actively recruiting, with the initial posting occurring on June 28th 2019 and an update taking place July 11th 2022. This trail seeks to recruit 100 patients from a single site."

Answered by AI

Are there still openings in this experiment open to participants?

"Clinicialtrials.gov reports that this research project is actively enlisting participants, having been first listed on June 28th 2019 and recently updated on July 11th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging

Joel M. Stein, MD, PhD 2019. "Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04436068.

All > Hydrocephalus